Neurocognition and Valve Disease: Incidence and Implications - Ronald Lazar, PhD, FAHA

↳ This is a section part of Moment: CRT 2016 Valve & Structural - Cerebral Embolic Protection Devices

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$9.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Neurocognition and Valve Disease: Incidence and Implications presented by Ronald Lazar, PhD, FAHA at CRT 2016

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$9.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists 
  • Structural Heart Specialists 
  • Interventional Fellows 
  • Cardiac Surgeons 
  • Imaging Specialists 
  • Radiologists

Session Name: Cerebral Embolic Protection Devices

Track: CRT Valve & Structural

Learning Objectives

  • Update in advances/best practice in Valve & Structural procedures

Other Components in this Moment

Overview
Neurocognition and Valve Disease: Incidence and Implications - Ronald Lazar, PhD, FAHA
Protection Devices for Stroke Prevention: Does the Data Support Routine Use? - Eberhard Grube, MD, FSCAI
Update on SENTINEL Trial Technology and Clinical Outcome - Susheel Kodali, MD, FSCAI
Technology Overview and Perspectives from the DEFLECT III Randomized Trial - Alexandra Lansky, MD, FSCAI
What Are the Options for Intervention of a Patient Who Has a Stroke after TAVR - Adnan Siddiqui, MD, PhD
Magnitude of Stroke Post-TAVR: Do We Need Cerebral Embolic Protection Devices? - Michael Mack, MD
Loading Simple Education